Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704418 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
A Phase 3 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 156
- Enrollment target
NCT00704418: Completed Phase 3 study, sponsored by Bausch & Lomb Incorporated.
NCT00704418 is a Phase 3 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 156 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00704418, a Phase 3 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 156 participants
- Enrollment target
Study Summary
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Primary Outcome
Participants with SOIS of 0. Scale: 0=0 cells (complete absence); 0.5=1-5 cells; 1=6-15 cells (very slight); 2=16-25 cells (moderate); 3=26-50 cells (marked); 4=\>50 cells (intense)
Interventions
- DRUG Placebo
- DRUG Bromfenac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
What the finished NCT00704418 record still lists
NCT00704418 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00704418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00704418 about?
NCT00704418 is a clinical study titled "Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery". Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
What is the current status of trial NCT00704418?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 156 participants. The study started on 2008-06. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00704418?
The interventions under investigation include: Placebo (DRUG), Bromfenac (DRUG).
Who is sponsoring clinical trial NCT00704418?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00704418's enrollment target sits among peer trials
156 1506th of 2000 higher than 492 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia